XML 23 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements Of Cash Flows (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Operating activities      
Net loss $ (83,903) $ (73,564) $ (45,889)
Adjustments to reconcile net loss to net cash used in operating activities:      
Stock-based compensation 4,809 2,507 1,026
Depreciation and amortization 1,584 1,428 1,017
Amortization of debt issuance costs and non-cash interest 1,793 1,582 4,297
Change in fair value of warrant liability (445) (6,725) 755
Change in fair value of embedded derivatives 240 0 0
Beneficial conversion feature from issuance of convertible notes 0 4,696 3,009
Loss on disposal and impairment of property and equipment 0 2 11
Changes in operating assets and liabilities:      
Trade accounts receivable (439) (4,474) 0
Inventory 2,042 (5,133) (13,160)
Prepaid expenses and other current assets 24 537 (1,769)
Other assets (187) (3,976) (176)
Accounts payable and accrued expenses 4,955 10,866 (396)
Deferred rent (57) (48) (86)
Deferred revenue (10,887) 350 19,000
Net cash used in operating activities (80,471) (71,952) (32,361)
Investing activities:      
Purchases of property and equipment (617) (3,442) (2,057)
Net cash used in investing activities (617) (3,442) (2,057)
Financing activities:      
Proceeds from issuance of common stock, net of issuance costs 59,527 51,733 0
Proceeds from issuance of convertible preferred stock, net of issuance costs 0 0 54,930
Proceeds from convertible notes, net of issuance costs 0 14,957 14,770
Proceeds from borrowings of debt and revolving credit facility, net of issuance costs 39,124 31,072 0
Payments on borrowings of debt (825) (18,178) (4,691)
Payments on revolving credit facility (9,477) 0 0
Proceeds from exercise of common stock options 92 71 95
Net cash provided by financing activities 88,441 79,655 65,104
Net increase in cash and cash equivalents 7,353 4,261 30,686
Cash and cash equivalents at beginning of period 49,172 44,911 14,225
Cash and cash equivalents at end of period 56,525 49,172 44,911
Supplemental disclosure of cash flow information:      
Cash paid for interest 4,186 2,403 1,894
Noncash investing and financing activities:      
Warrants issued in connection with debt 866 0 0
Embedded derivatives related to debt 605 0 0
Purchase of property and equipment in accounts payable 123 126 213
Vesting of early exercised stock options 15 59 54
Conversion of convertible preferred stock to common stock at initial public offering 0 149,312 0
Conversion of convertible notes and related interest to common stock, net of issuance costs 0 15,477 0
Reclassification of convertible preferred stock warrants to common stock warrants 0 743 0
Acquisition of leasehold paid by landlord 0 305 0
Conversion of convertible notes and related interest to convertible preferred stock, net of issuance costs 0 0 15,258
Warrants issued in connection with debt and convertible preferred stock $ 0 $ 0 $ 3,819